These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


687 related items for PubMed ID: 18266754

  • 1. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
    Specchio N, Boero G, Michelucci R, Gambardella A, Giallonardo AT, Fattouch J, Di Bonaventura C, de Palo A, Ladogana M, Lamberti P, Vigevano F, La Neve A, Specchio LM.
    Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
    [Abstract] [Full Text] [Related]

  • 2. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
    Specchio LM, Gambardella A, Giallonardo AT, Michelucci R, Specchio N, Boero G, La Neve A.
    Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521
    [Abstract] [Full Text] [Related]

  • 3. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
    Verrotti A, Cerminara C, Coppola G, Franzoni E, Parisi P, Iannetti P, Aloisi P, Tozzi E, Cusmai R, Vigevano F, Chiarelli F, Curatolo P.
    Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
    [Abstract] [Full Text] [Related]

  • 4. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE, Benbadis S, Edrich P, Tassinari CA, Hirsch E.
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of a morning routine EEG recording in patients with juvenile myoclonic epilepsy.
    Labate A, Ambrosio R, Gambardella A, Sturniolo M, Pucci F, Quattrone A.
    Epilepsy Res; 2007 Oct; 77(1):17-21. PubMed ID: 17851038
    [Abstract] [Full Text] [Related]

  • 6. Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes.
    Di Bonaventura C, Fattouch J, Mari F, Egeo G, Vaudano AE, Prencipe M, Manfredi M, Giallonardo AT.
    Epileptic Disord; 2005 Sep; 7(3):231-5. PubMed ID: 16162433
    [Abstract] [Full Text] [Related]

  • 7. Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases.
    Aeby A, Poznanski N, Verheulpen D, Wetzburger C, Van Bogaert P.
    Epilepsia; 2005 Dec; 46(12):1937-42. PubMed ID: 16393159
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, Vajda FJ.
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [Abstract] [Full Text] [Related]

  • 9. Benign myoclonic epilepsy in infants: electroclinical features and long-term follow-up of 34 patients.
    Auvin S, Pandit F, De Bellecize J, Badinand N, Isnard H, Motte J, Villeneuve N, Lamblin MD, Vallée L.
    Epilepsia; 2006 Feb; 47(2):387-93. PubMed ID: 16499765
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV, Valencia I, Khurana DS, Hardison H, Melvin JJ, Legido A.
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M.
    Epilepsia; 2001 Dec; 42 Suppl 4():31-5. PubMed ID: 11564123
    [Abstract] [Full Text] [Related]

  • 12. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [Abstract] [Full Text] [Related]

  • 13. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group.
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [Abstract] [Full Text] [Related]

  • 14. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C, Ishihara K, Nagayama T, Serikawa T, Sasa M.
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Levetiracetam monotherapy for childhood occipital epilepsy of gastaut.
    Verrotti A, Parisi P, Loiacono G, Mohn A, Grosso S, Balestri P, Tozzi E, Iannetti P, Chiarelli F, Curatolo P.
    Acta Neurol Scand; 2009 Nov; 120(5):342-6. PubMed ID: 19754870
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.